Skip to main content
Updating results

Patient

  • Updated

The COVID-19 comeback across the U.S. is putting pressure on hospitals at a time when some of them are busy just trying to catch up on surgeries and other procedures that were put on hold during the pandemic.

  • Updated

Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment.

  • Updated

Answer: The Food and Drug Administration said it granted approval to a drug from Biogen based on clinical research results that seemed “reasonably likely” to benefit Alzheimer’s patients.

  • Updated

Answer: They will likely request some documentation first that the patient needs the drug. Many plans will require doctors to submit records and other paperwork justifying the treatment before they agree to cover it.

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News